Russia begins producing third COVID-19 jab CoviVac – ministry
MOSCOW — Russia has started producing CoviVac, its third vaccine against COVID-19, and will soon make it available for use in its regions, though phase three trials are still underway, officials said Thursday.
The most well-known Russian coronavirus vaccine is Sputnik V. Moscow has also given emergency approval to two shots, EpiVacCorona and CoviVac.
“The third Russian vaccine is entering civilian circulation and will appear in the regions in the coming days,” the Science and Higher Education Ministry said in a statement.
The Chumakov Center plans to produce up to 10 million doses of the vaccine a year, the ministry said.
Science Minister Valery Falkov said that phase three trials of the vaccine had begun, the Interfax news agency reported.
The Chumakov Centre’s director said phase three trials would be completed within half a year, Interfax reported.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.